Raymond Fitzpatrick

Title: Professor of Clinical Pharmacy
Phone: 01782733563
Email: r.fitzpatrick@keele.ac.uk
Location: HNB2.18
Role: ISTM Research Theme: Sustainable Pharmacy
Contacting me: Try my office or arrange an appointment via e-mail

I graduated from Manchester University with a first class honours degree in Pharmacy in 1974, and was awarded a PhD from Manchester University in 1978. 

I have worked as a hospital pharmacist in the NHS for 36 years of which 24 years as a chief pharmacist.  I was Director of Pharmacy at the University Hospital of North Staffordshire and Senior Lecturer at Keele University from 1991-2003, during which time I was also Director of Research and Development for the Hospital.

I moved to become Clinical Director of Pharmacy at Royal Wolverhampton NHS Trust in February 2003.  I was also Professor of Pharmacy at Wolverhampton University from 2004 to 2014, and was instrumental in establishing the undergraduate School of Pharmacy at the University. 

In 2014 I was seconded to the Centre for Medicines optimisation at Keele University as Secondary Care Pharmaceutical advisor and Professor of Clinical Pharmacy, and I continue to work here following my retirement from the NHS in November 2015.

In 2007 I was made a Fellow of the Royal Pharmaceutical Society for distinction in the Profession of Pharmacy and in 2013 I was made a Fellow of the Faculty of the Royal Pharmaceutical Society. I received a lifetime achievement award from the Royal Pharmaceutical Society in 2015 for innovation, leadership and outstanding contribution to pharmacy and a lifetime achievement award from Royal Wolverhampton NHS Trust in 2016.

Having spent over two thirds of my career as a Hospital Chief Pharmacist, I have developed a special interest in Medicines Optimisation and Pharmacy practice research, with over 100 publications in journals and book chapters and presentations at national and international conferences.  I have also acted as an advisor to NHS and government bodies on medicines management and prescribing issues.

My current research interests include:

  • The uptake of biosimilars medicines in the NHS.
  • Antibiotics and Clostridium Difficle
  • Hospital Pharmacy workforce issues.
  • Fitzpatrick R. and Maddock K. Practical Pharmacokinetics. In: Whittlesea C. and Hodson K., editors. Clinical Pharmacy and Therapeutics Sixth Edition: Churchill Livingstone Elsevier, In Press 2017.
  • Chapman S.R, Fitzpatrick R.W, and Aladul M. I. What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences. BMJ Open, Accepted  17th February 2017.
  • Ramsbottom H, Rutter.P,and Fitzpatrick R. Post discharge medicines use review (dMUR) service for older patients: Cost-savings from community pharmacist interventions. Research in Social and Administrative Pharmacy, Accepted 10th February 2017.
  • Rutter P, Ramsbottom H and Fitzpatrick R. Community pharmacist perceptions of delivering post-hospital discharge Medicines Use Reviews for elderly patientsInternational Journal of Clinical Pharmacy, 2017; 39 (1): 33-36
  • Fitzpatrick R.W and Sanders S.  Hospital pharmacy staffing levels in England: has anything changed in the last 5 years.  European Journal of Hospital Pharmacy.  2016; 23: 327-330.
  • Ramsbottom H.F, Fitzpatrick R, and Rutter P. Post discharge medicines use review service for older patients: recruitment issues in a feasibility study.  International Journal of Clinical Pharmacy.  2016; 38: 208-212
  • Fitzpatrick R.W and Pate R.G. Assessing the Impact of NICE Guidance on the Prescribing of Hormonal Treatments of Breast Cancer in England.  Journal of Evaluation in Clinical Practice. 2015; 21:759-761
  • Rutter J, Fitzpatrick R, and Rutter P.  What Effect does Medicines Advice provided by UK Medicines Information Pharmacists have on Prescriber practice and patient care: a qualitative primary care study.  Journal of Evaluation in Clinical Practice,  2015; 21: 307-312

Journal Articles

  • Chapman S.R, Fitzpatrick R.W, and Aladul M. I. What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences. BMJ Open. Accepted  17th February 2017.
  • Ramsbottom H, Rutter.P,and Fitzpatrick R. Post discharge medicines use review (dMUR) service for older patients: Cost-savings from community pharmacist interventions. Research in Social and Administrative Pharmacy. Accepted 10th February 2017.
  • Rutter P, Ramsbottom H and Fitzpatrick R. Community pharmacist perceptions of delivering post-hospital discharge Medicines Use Reviews for elderly patients. International Journal of Clinical Pharmacy, 2017; 39 (1): 33-36
  • Fitzpatrick R.W and Sanders S.  Hospital pharmacy staffing levels in England: has anything changed in the last 5 years.  European Journal of Hospital Pharmacy.  2016; 23: 327-330.
  • Ramsbottom H.F, Fitzpatrick R, and Rutter P. Post discharge medicines use review service for older patients: recruitment issues in a feasibility study.  International Journal of Clinical Pharmacy.  2016; 38: 208-212
  • Fitzpatrick R.W and Pate R.G. Assessing the Impact of NICE Guidance on the Prescribing of Hormonal Treatments of Breast Cancer in England.  Journal of Evaluation in Clinical Practice. 2015; 21:759-761
  • Rutter J, Fitzpatrick R, and Rutter P.  What Effect does Medicines Advice provided by UK Medicines Information Pharmacists have on Prescriber practice and patient care: a qualitative primary care study.  Journal of Evaluation in Clinical Practice,  2015; 21: 307-312
  • Fitzpatrick R, Scott D and Keary I.  Cost-minimisation analysis of subcutaneous methotrexate versus biologic therapy for the treatment of patients with rheumatoid arthritis who have had an insufficient response or intolerance to oral methotrexate. Clinical Rheumatology, 2013; 32 (11): 1605-1612.
  • McKean F, Fletcher-Shields E, and Fitzpatrick R.  The Impact of Electronic Medicines Management on Ward Based Pharmacy Services. Pharmacy Management, 2012; 28 (3):13-16.
  • Fitzpatrick R.W. Pharmacoeconomics of Subcutaneous Methotrexate.  Hospital Pharmacy Europe, 2012: 61; 51-54
  • Pate R and Fitzpatrick R.W. Escalating Hospital medicines Expenditure: Time for Action.  British Journal of Medicines Procurement, 2011: 3 (2); 11-13
  • Fitzpatrick R.  Indicators for Comparing Hospital Medicines Use.  Hospital Pharmacy Europe 2011: 55; 51-53.
  • Fitzpatrick R.  Comparison of staffing establishments in hospital pharmacies in England.  Pharmaceutical Journal, 2010; 284: 504-506
  • Pate R.G, Fitzpatrick R.W, and Woodvine P.  Does Secondary care impact on primary care prescribing performance?  Pharmaceutical Journal, 2009; 283: 625-626.
  • Pate R.G, Fitzpatrick R.W, and Woodvine P.  Using prescribing activity comparators to change medicines use in secondary care. Pharmaceutical Journal, 2009; 283: 597- 598.
  • Fitzpatrick R.W. and Pate R.G. Comparing the use of inhalational anaesthetics. Pharmaceutical Journal, 2009; 283: 540-541.
  • Pate R.G. and Fitzpatrick R.W. How can we compare medicines use in hospitals?  British Journal of Clinical Pharmacy, 2009; 1(7): 212- 214.
  • Pate R.G. and Fitzpatrick R.W. Why we need to compare medicines use in hospitals.  British Journal of Clinical Pharmacy, 2009; 1 (6): 179-180.
  • Fitzpatrick R. W and Pate R.G. Hospital Prescribing: A Taste of each others Medicine. Health Services Journal, 2008; November 13 : 28-29
  • Fitzpatrick R.W.  Automating the Medicines Supply Chain.  Hospital Pharmacy Europe, 2008; 39: 77-79.
  • Fitzpatrick R.W. and Edwards C.M. Evaluation of a Tool to Benchmark Hospital Antibiotic Prescribing in The United Kingdom. PharmacyWorld and Science, 2008; 30: 73-78.
  • Fitzpatrick R.W. et al. How Hospital Teacher Practitioners contribute to Undergraduate and pre-registration Education and Training, Pharmaceutical Journal, 2007; 278: 165-167
  • Smith I, Cooke T, Jackson I and Fitzpatrick R.  Rising to the Challenges of Achieving Day Surgery Targets. Anaesthesia, 2006 ; 61: 1191-1199.
  • Fitzpatrick R, Cooke P, Southall C, Kauldhar K, and Waters P, Evaluation of an Automated Dispensing System.  Pharmaceutical Journal, 2005; 74: 763-765.
  • Fitzpatrick R. W, and Boardman H, A Survey of the provision of Clinical Pharmacy Services in Relation to Existing Standards.  Pharmacy World and Science, 2005; 27 (3):191-196.
  • Fitzpatrick R.W, Pharmacy without Walls, Health Management, 2004; 8 (7): 22-24.
  • Fitzpatrick R.W.  Automated Dispensing- developing the business case to support investment, Hospital Pharmacist, 2004; 11 (3): 109-111.
  • Fitzpatrick R.W. Implementing Automation in a Hospital Pharmacy, Hospital Pharmacy Europe, 2004; March/April, 34-37.
  • Fitzpatrick R, Rajaratnam G, and Kinsey J,  Implementation of NICE Guidance across a Health Economy.  Clinical Excellence, 2002; 4: 318-320
  • Curtis C, Fitzpatrick R.W, and Marriott J.  An Evaluation of Quinolone Prescribing in a Group of Acute Hospitals: Development of an Objective Measure of Usage. Pharmacy World and Science,  2002; 24 (2): 61-66.
  • Stringer N.J, Fitzpatrick R.W, and Brunt A.M, Economic Evaluation of a Standard Dosage System for an Outpatient Breast Cancer Chemotherapy Regimen. The International Journal of Pharmacy Practice,   2001; 9: 185-189
  • Boardman H, and Fitzpatrick R.W.  Self Reported Clinical Pharmacist Interventions Under-estimate Their Input to Patient Care, Pharmacy World and Science, 2001; 23 (2): 55-59
  • Fitzpatrick R.W,  Mucklow J.C. and Fillingham D.  Managing Medicines in Secondary Care: A Comprehensive System.  Pharmaceutical Journal,  2001;266: 588-589
  • Fitzpatrick R.W. and Capper J.  Operating a Needle Exchange Scheme: The North Staffordshire Experience.  Pharmaceutical Journal, 2000; 264: 852-853.
  • Yanny H, Johanson R, Baldwin J, Lucking L, Fitzpatrick R and Jones P.  Double-blind randomised controlled trial of glyceryl trinitrate spray for External Cephalic Version. British Journal of Obstetrics and Gynaecology, 2000; 107: 562-564.
  • Fitzpatrick R.W, Marriott J.F. and Wilson K.A. What Future for Pharmacy Practice Research? Pharmaceutical Journal, 1999; 262: 22.
  • Metcalfe A.M. and Fitzpatrick R.W. Is the Management of research and Development Really Necessary?  Midlands Medicine, 1998; 20 (6): 122-123.
  • Fitzpatrick R.W.  Is There a Place for Drug and Therapeutics Committees in the New NHS?  European Hospital Pharmacy, 1997; 3 (4): 143-147.
  • Manley N.M, Fitzpatrick R.W, Long T. and Jones P.W.  A Cost Analysis of Alfentanil/Propofol versus Morphine/Midazolam for the Sedation of Critically ill Patients. Pharmacoeconomics, 1997; 2  (pt 2): 247-255.
  • Fitzpatrick R.W. Hospital Pharmacy: have we come full circle?  Pharmacy Management, 1997; 13 (2): 15-17.
  • Fitzpatrick R.W.  Life after Culyer. Pharmaceutical Journal, 1997; 258:  242.
  • Fitzpatrick R.W. and Mucklow J.C.  Pharmacy in St Petersburg.  Pharmaceutical Journal, 1996; 257: 931-933.
  • Panton R.S. and Fitzpatrick R.W.  The Involvement of Pharmacists in Professional and Clinical Audit in The UK: A Review and Assessment of Their Potential Role.  Journal of Evaluation in Clinical Practice,  1996; 2 (3): 193-198.
  • Langford S.A., Sugden J.K. and Fitzpatrick R.W.  Detection and Determination of the Hydrazo and Azo  Photoproducts of  4-Aminobenzoic acid by High-performance Liquid Chromatography.  Journal of Pharmaceutical and Biomedical Analysis, 1996; 14: 1615-1623.
  • Hynam B. and Fitzpatrick R.W. Purchasing and Prescribing - E.L.(94)72.  Pharmacy Management, 1995; 10 (3): 37-39.
  • Fitzpatrick R.W., Hynam B.M. and Phillips W.M. Audit in Hospital Pharmacy: Three Years of Experience. Pharmaceutical Journal, 1994; 253: 31-33.
  • Fitzpatrick R.W. Changing the Method of Maintaining Indwelling Intravenous Catheters: A Pharmacy Initiative. The International Journal of Pharmacy Practice, 1993; 2 (1): 35-38.
  • Mann J.S, Fitzpatrick R.W, Jones P.W, Prowse K, Mucklow J.C. and Cole R.B. A Single Oral Dose Method for Predicting Steady State Theophylline Concentrations in Clinical Practice. Respiratory Medicine, 1990; 84: 479-484.
  • Allen M.B., Fitzpatrick R.W., Barratt A. and Cole R.B. The Use of Probenecid to Increase Serum Amoxycillin Levels in Patients with Bronchiectasis. Respiratory Medicine 1990; 84: 143-146.
  • Fitzpatrick R.W. Evaluation of a Clinical Pharmacokinetics Training Programme. Pharmaceutical Journal, 1989; 242 (supp): 18-19.
  • Bourne J.S., Brown N.S., Cottrell W.N., Faulder G.C., Fitzpatrick R.W., Moult J.A. and Mucklow J.C. Drug Levels and The Prescriber: A Prospective Study of A Therapeutic Drug Monitoring Service. Midlands Medicine, 1988; 17 (6): 164-166.
  • Radley A.S. and Fitzpatrick R.W. Evaluation of the Potential Interaction Between Enalapril and Amiloride. Journal of Clinical Pharmacy and Therapeutics, 1987; 12: 319-323.
  • Donnelly J.D. and Fitzpatrick R.W. A Documentation System For Adult Parenteral Nutrition. British Journal of Pharmaceutical Practice, 1987; 9: 116-126.
  • Cottrell W.N., Donnelly J.D. and Fitzpatrick R.W. Instigation of a Neonatal T.P.N. Service. Pharmaceutical Journal, 1986; 237: 278-279.
  • Cottrell W.N. and Fitzpatrick R.W. Determination of the In-Vivo Concentration Time Profile of Chlorhexidine and Noxythiolin in Bladder Irrigations. Journal of Clinical and Hospital Pharmacy, 1986; 11: 335-342.
  • Fitzpatrick R.W. and Moss-Barclay C. The Effectiveness of Drug Level Monitoring and Pharmacokinetics in Individualising Theophylline Therapy.  Journal of Clinical and Hospital Pharmacy, 1985; 10: 279-287.
  • Bourne J.G., Farrar K.T. and Fitzpatrick R.W. Practical Involvement in Therapeutic Drug Monitoring. Pharmaceutical Journal, 1985; 234: 530-531.
  • Fernley D. and Fitzpatrick R.W. Improving Compliance in The Elderly. Pharmaceutical Journal, 1983; 231: 75-76.
  • Moss-Barclay C. and Fitzpatrick R.W. In-Service Training in Pharmacokinetics. Pharmaceutical Journal, 1983; 231: 21-22.
  • Fitzpatrick R.W. A Theophylline Induced Seizure. British Journal of Pharmaceutical Practice 1982: 4 (5): 16-17.
  • Fitzpatrick R.W. The Pharmacist in the Clinical Area: A Practical Account. British Journal of Pharmaceutical Practice 1981; 3 (9): 18-22.
  • Fitzpatrick R.W., Jackson H. and Dickenson N.A. Effect of Racemic and S-1-(+)-   Chlorohydrin-1-Phosphate on Glyceraldehyde-3~Phosphate Dehydrogenase in Relation to its Contraceptive Action. Contraception 1978; 18 (5): 477- 483.
  • Jackson H., Rooney F.R., Fitzpatrick R.W. and Gibson K.H. Characterisation and Antifertility Activity in Rats of S-(+)-- Chlorohydrin. Chemical and Biological Interactions 1977; 17: 117-120.

Book Chapters

  • Fitzpatrick R. and Maddock K. Practical Pharmacokinetics. In: Whittlesea C. and Hodson K., editors. Clinical Pharmacy and Therapeutics Sixth Edition: Churchill Livingstone Elsevier, In Press 2017.
  • Fitzpatrick R. and Kostrzewski A. Practical Pharmacokinetics. In: Walker R. and Edwards C., editors. Clinical Pharmacy and Therapeutics Fifth Edition: Churchill Livingstone, London 2011.
  • Fitzpatrick R. Practical Pharmacokinetics. In: Walker R. and Edwards C., editors. Clinical Pharmacy and Therapeutics Fourth Edition: Churchill Livingstone, London 2007.
  • Fitzpatrick R.W. Strategic Medicines Management. In Stephens M, editor, Hospital Pharmacy: Pharmaceutical Press, London 2003
  • Fitzpatrick R. Practical Pharmacokinetics. In: Walker R. and Edwards C., editors. Clinical Pharmacy and Therapeutics Third Edition: Churchill Livingstone, London 2003.
  • Fitzpatrick R.W. and Coker N.  Systems for Controlling Prescribing. In Medicines Management. Edited by Panton R.S. and Chapman S.  B.M.J. Publishing, London 1998.
  • Fitzpatrick R. Practical Pharmacokinetics. In: Walker R. and Edwards C., editors. Clinical Pharmacy and Therapeutics Second Edition: Churchill Livingstone, London 1998.
  • Fitzpatrick R. Practical Pharmacokinetics. In: Walker R. and Edwards C., editors. Clinical Pharmacy and Therapeutics. London: Churchill Livingstone, 1994: 3-20.

Other Publications

  • Chapman S.R, Fitzpatrick R.W, and Aladul M. I.  Is the uptake in use of Biosimilars similar to generic medicines?' Presented at the Prescribing and research in Medicine Management Conference London 2017.
  • Capman S.R, Fitzpatrick R.W, and Aladul M. I.  Did cost inhibit the uptake of more potent statins. Presented at the Prescribing and research in Medicine Management Conference London 2016.  Pharmacoepidemiology and Drug Safety, 2016; 25: 7.
  • Fitzpatrick R.  Is Wolverhampton showing the way for pharmacists in GP practices? Health Services Journal,  22nd July 2015.
  • Fitzpatrick R.W. Homecare Medicines: Maximising the Benefits and Reducing the Risks. Presented at Hospital Pharmacy Live, October 2014, Hospital Pharmacy Europe, 2014;76: 11
  • Fitzpatrick R.W.  Antimicrobial Stewardship as Part of a Holistic Approach to Infection Prevention and Control. Presented at the British Pharmaceutical Conference Birmingham 8th September 2014. By Invitation
  • Fitzpatrick R.W. Benchmarking Drug Utilisation in Hospital Pharmacy.  Presented at the 19th Congress of the European Association of Hospital Pharmacists, Barcelona, Spain, March 2014. By Invitation
  • Fitzpatrick R.W and Pate R. To investigate the relationship between the use of short acting Inhalational anaesthetics and rates of day case surgery in England. Presented at the 46th ASHP Midyear Clinical meeting, New Orleans, USA, December 2011
  • Fitzpatrick R.W.  Optimal Use of Resources in treating Oral Methotrexate Failure Patients.   Presented at a satellite symposium of the Eular Annual European Congress of Rheumatology, London, May 2011
  • Fitzpatrick R.W. Editorial: Hospital Acquired Infection: Challenges and opportunities,  Hospital Pharmacy Europe, 2009; 42: 5
  • Fitzpatrick R.W. Opinion Article: How Hospital Pharmacists will be represented in the new Professional body.  Clinical Pharmacist, 2009; 1 (4): 154.
  • Fitzpatrick R.W. Editorial: Who Checks the Pharmacist? Hospital Pharmacy Europe, 2008; 41: 7
  • Fitzpatrick R.W. and Pate R. G.  A Hospital Prescribing: A Taste of Each Others Medicine Health Services Journal, November 13 2008.
  • Fitzpatrick R.W. Editorial: The effect on pharmacy of the changing medicines landscape.  Hospital Pharmacy Europe, 2008; 40: 7
  • Fitzpatrick R.W. Editorial: Addressing the question of professional leadership. Hospital Pharmacy Europe, 2008; 39: 7.
  • Fitzpatrick R.W. Editorial: Patient Centred and Medicines Focused Pharmacy Practice.  Hospital Pharmacy Europe, 2008; 38: 7
  • Fitzpatrick R.W. Editorial: Beware the illusion of communication. Hospital Pharmacy Europe, 2008; 37: 7
  • Fitzpatrick R.W. Editorial: Sharing knowledge, practice, and experience. Hospital Pharmacy Europe, 2008; 36: 7
  • Ramsbottom H, Rutter P, Fitzpatrick R.  A questionnaire survey of hospital pharmacists’ views on recruiting older patients to a post discharge medicines use review (dMUR) service.  Int J Pharm Pract. 2016;24(Supp1):39
  • Fitzpatrick R.W. Editorial: Science, responsibility, and professionalism. Hospital Pharmacy Europe, 2007; 35: 7.
  • Fitzpatrick R.W. and Pate R.G. Development of an Indicator to Compare Hospital Use of Sevoflurane.  Presented at the 42nd Mid-year Meeting of the American Society of Health     System Pharmacists, Las Vegas, 2007. 
  • Fitzpatrick R.W. We must not stand still - reacting to the changes of 2007, Hospital Pharmacist, 2007; 14 (11): 358
  • Fitzpatrick R.W. Editorial: New perspectives in oncology. Hospital Pharmacy Europe, 2007; 34: 7
  • Fitzpatrick R.W. Editorial: A Vision for tomorrow: hospital pharmacy without walls. Hospital Pharmacy Europe, 2007; 33: 7
  • Fitzpatrick R.W. Editorial: The safety of injectable medicines. Hospital Pharmacy Europe, 2007; 32: 7
  • Fitzpatrick R.W. Editorial: Illuminating the therapeutic path. Hospital Pharmacy Europe, 2007; 31:7
  • Fitzpatrick R.W. Editorial: Specialisation in hospital pharmacy. Hospital Pharmacy Europe, 2007; 30:7
  • Fitzpatrick R.W. Comment Article: Reflecting on 2006 – a year of change for Hospital      Pharmacy, Hospital Pharmacist, 2006; 13 (11): 386.
  • Fitzpatrick R.W. Editorial: Making a difference as hospital pharmacists. Hospital Pharmacy Europe, 2006; 29: 7
  • Fitzpatrick R.W. Editorial: The different costs of high technology medicines. Hospital Pharmacy Europe, 2006; 28: 7
  • Fitzpatrick R.W. Editorial: Pharmaceutical Care or Medicines Management. Hospital Pharmacy Europe, 2006; 27: 7
  • Fitzpatrick R.W. Editorial: Antibiotics management: the pharmacist’s role. Hospital Pharmacy Europe, 2006; 26: 7
  • Fitzpatrick R.W. Editorial: Personalised medicines: the future of pharmacy? Hospital  Pharmacy Europe, 2006; 25: 7
  •  Fitzpatrick R.W. Editorial: Transatlantic perspectives: lessons to be learned. Hospital Pharmacy Europe, 2006; 24: 7
  • Fitzpatrick R.W. Editorial: Treating cancer: more of a science, less of an art. Hospital Pharmacy Europe, 2005; 23: 5
  • Fitzpatrick R.W. Editorial: New technology and the Pharmacy without Walls. Hospital Pharmacy Europe, 2005; 22: 5
  • Fitzpatrick R.W. Editorial: Professional practice in a changing environment.  Hospital Pharmacy Europe, 2005; 21: 5
  • Fitzpatrick R.W. Editorial: The pharmacists role in emergency situations.  Hospital Pharmacy Europe, 2005; 20: 5
  • Fitzpatrick R.W. Editorial: Using new technologies in hospital pharmacy.  Hospital Pharmacy Europe, 2005; 19: 5
  • Fitzpatrick R.W. Editorial: Medicines Management is Risk Management.  Hospital Pharmacy Europe, 2005; 18: 5.
  • Fitzpatrick R.W. Is it time we shared good practice in Supplementary prescribing? Hospital Pharmacist, 2004; 11 (11): 442
  • Ranson C, Fitzpatrick R.W, Green D, Allen C, Seed M, & Lewis S, The Validation of a Medicines Risk Assessment Tool: a Pilot Study, presented at The British Pharmaceutical Conference, Harrogate, 2003, International Journal of Pharmacy practice, 2003, 11: R22.
  • Fitzpatrick R.W. Evaluating Medicines Management.  Presented at the Hospital Pharmacist Conference, London, 2001. Hospital Pharmacist, 2001; 8 (10): 270.
  • Fitzpatrick R.W. Medicines Management in Practice.  Presented at The British Pharmaceutical Conference, Glasgow, 2001. Pharmaceutical Journal, 2001; 267: 473
  •  Fitzpatrick R.W. and Mucklow J.C. Managing  The Introduction of New Medicines in   Hospital.  Presented at The Guild of Healthcare Pharmacists Day Conference,  Birmingham, 2000. G.H.P. 2001; 2 (4): 13.
  • Fitzpatrick R.W. Take Care of Patients and The Law. In Ethical Dilemmas series, editedby Daly M.J & Bower A.  Pharmacy in Practice, 1999; 9 (4):135-136.
  • Boardman H.F. and Fitzpatrick R.W., Validating Clinical Pharmacists Self Assessments  of Interventions.  Presented at The UKCPA Annual Symposium, Leicestershire, 1998.  Pharmacy World and Science, 1999; 21 (1): A15.
  • Boardman H.F. and Fitzpatrick R.W, Clinical Pharmacists Intervention Records - How  are They Used ?  Presented at The UKCPA Annual Symposium, Leicestershire, 1998.  Pharmacy World and Science, 1999; 21 (1): A9.
  • Fitzpatrick R.W. Implementing a Comprehensive Medicines Management System, Presented at The Mid year Clinical Meeting of the American Society of Health System Pharmacists, Las Vegas, International Pharmaceutical Abstracts, 1998; 35 (21): 2246.
  • Fitzpatrick R.W. Policy Influences on Clinical Pharmacy, Presentation at The Pan Thames  Clinical Pharmacy Symposium 1998 (Invited), Pharmaceutical Journal, 1998; 261: 100.
  • Watson A., Fitzpatrick R. W. and Chapman S. An Investigation into the Pharmaceutical      Information Needs of Patients with Epilepsy.  Presented at the U.K.C.P.A. Annual Residential Symposium, Blackpool 1997. Pharmacy World and Science, 1998; 20 (1): A16.
  • Boardman H and Fitzpatrick R.W.  Managing Clinical Pharmacy: Empowerment of         Clinical Pharmacist.  Presented at the U.K.C.P.A  Annual Residential Symposium,  Blackpool 1997.  Pharmacy World and Science, 1998; 20 (1): A11.
  • Goodwin N. J. and Fitzpatrick R.W.  Impact on Pharmacy staff utilisation by the      Implementation of a Standardised Dosage System for an Outpatient Breast Cancer Chemotherapy regimen.  Presented at the 32nd Mid-year Clinical Meeting of the American Association of Health System Pharmacists, Atlanta, Georgia, 1997.  International Pharmaceutical Abstracts, 1997; 34 (21): 2179.
  • Goodwin N, Brunt M and Fitzpatrick R.W.  Development of a dosage calculator for CMF Therapy.  Presented at the 5th International Breast Cancer Conference, Nottingham, 1997.
  • Fitzpatrick R.W. A Business Plan For Hospital Pharmacy. Invited Presentation at The British Pharmaceutical Conference, Scarborough 1997,  Pharmaceutical Journal  1997;  259: 618.
  • Lock J.A., Watson V.A. and Fitzpatrick R.W.  Pharmacoeconomic Evaluation of Ticarcillin/Clavulanic acid Versus Piperacillin /Tazobactam in Patients with Febrile Neutropenia. Presentation at the Midyear Meeting of The American Society of Health System Pharmacists, New Orleans 1996, International Pharmaceutical Abstracts, 1996; 33 (21): 2293.
  • Manley N., Fitzpatrick R.W. and Long T.  A Pharmacoeconomic Study of Alfentanil/Propofol  versus Morphine/Midazolam for the Sedation of Critically ill Patients.  Presentation at  The Midyear Meeting of The American Society of Health System  Pharmacists, Las Vegas 1995,  International Pharmaceutical Abstracts 1995; 32 (21): 2396.
  • Manley N., Fitzpatrick R.W. and Long T.  A Pharmacoeconomic Study of Alfentanil/Propofol  versus Morphine/Midazolam for the Sedation of Critically ill Patients. Presentation at The British Pharmaceutical Conference, Warwick 1995,  Pharmaceutical  Journal  1995; 225: R38.
  • Manley N, Long T. and Fitzpatrick R.W.  Comparison of Quality of Sedation, Recovery Characteristics and Cost implications of  Alfentanil/Propofol  Vs Morphine/Midazolam for Sedation of Patients in Intensive Care.  Presented at the Joint Meeting of The Intensive care Society and Societe De Reanimation De Langue Francaise.  Brighton 1995, International Journal of Critical Care Medicine, 1995; 6 (4): 20
  • Fitzpatrick R.W. Health Economics Should be Part of Undergraduate Pharmacy Teaching. Presented at The Debate on Topical Issues, British Pharmaceutical  Conference, Reading, 1993. Pharmaceutical Journal 1993; 251: 423.
  • Fitzpatrick R.W. Peer Group Audit. Presentation at The Royal Pharmaceutical Society's Conference on Professional Audit, London, 1993. Pharmaceutical Journal 1993; 251: 429.
  • Puranik A., Fitzpatrick R.W. and Ananthanarayanan T.S. Monitor Serum Theophylline (case report). Care of The Elderly 1993; 5 (6): 237.
  • Fitzpatrick R.W., Pharmacy Initiatives Result in Savings on Drug Expenditure. Presentation at a Management Symposium, Birmingham 1991. Pharmaceutical Journal 1991; 247: 779.
  • Munro H., Fitzpatrick R.W. and Jepson M., Patients Understanding of Lithium Therapy Before Attending a Lithium Clinic. Presentation at The British Pharmaceutical Conference 1991. Pharmaceutical Journal 1991; 247: R24.
  • Culshaw M. and Fitzpatrick R.W. Assessing The Effectiveness of a Laxative Bulletin Using D.U.R. Presentation at The U.K. D.U.R. Group Symposium, Oxford April 1991.
  • Fitzpatrick R.W. Undergraduate Clinical Pharmacy Training Fails to Reflect Current Practice. Presentation at The Debate on Topical Issues, British Pharmaceutical Conference, Cardiff 1990. Pharmaceutical Journal 1990; 245: 334.
  • Blackshaw C. Watson A. and Fitzpatrick R.W. Changes In Patients Warfarin Requirements Following Discharge From Hospital. Presentation at The Poster Session of The British Pharmaceutical Conference, Cardiff 1990. Pharmaceutical Journal 1990; 245: R240.
  • Fitzpatrick R.W., Edwards C. and Kane S. Variability in Chloramphenicol Pharmacokinetics in Children: A Case For Therapeutic Drug Monitoring. Presentation At The British Pharmaceutical Conference, Keele 1989. Pharmaceutical Journal 1989; 243: R25.
  • Fitzpatrick R.W., Mann J.S., Jones P.W. Prowse K.P., Mucklow J.C. and Cole R.B. A Comparison of Two Theophylline Dose Prediction Methods In Obstructive Lung Disease. Presentation at The British Thoracic Society Conference. Thorax 1989; 44 (10): 879p.
  • Fitzpatrick R.W. Use of Pharmacokinetics in Improving the Quality of Antibiotic Therapy. Presentation at the Guild of Hospital Pharmacists Day Symposium. Pharmaceutical Journal, 1988; 241 (supp): 28.
  • Allen M.B., Fitzpatrick R.W., Barrat A. and Cole R.B. Amoxycillin With and Without Probenecid in The Management of Patients With Bronchietasis. Presentation at the Poster session of The Medical Research Society 1988. Clinical Science, 1988; 74 (supp. 18): 56.
  • Allen M.B., Fitzpatrick R.W., Barrat A. and Cole R.B. Amoxycillin versus Amoxycillin Plus Probenecid Treatment in Patients with Bronchiectasis. Presentation at the Poster Session of the British Thoracic Society Conference 1987. Thorax, 1987; 42 (9): 740.
  • Fitzpatrick R.W. and Bye R.B. Effectiveness of a Pharmacokinetic Method of Predicting Maintenance Lithium Dosage. Presentation at the Poster session British Pharmaceutical Conference 1986. Pharmaceutical Journal, 1986; 237: 726.
  • Fitzpatrick R.W. Pharmacokinetic Individualisation of Theophylline Therapy. Presentation at the British Pharmaceutical Conference, London 1983. Pharmaceutical Journal, 1983; 231: 384.
  • Fitzpatrick R.W. and Thompson A.R. Comparison of Two Drug Distribution Systems in a District General Hospital.  Presentation at the Poster Session, Guild of Hospital Pharmacists Weekend School, Durham 1982.
  • Fitzpatrick R.W. Undergraduate Clinical Pharmacy Training at Oldham and District General Hospital. Presented at the Poster session Guild of Hospital Pharmacists Weekend School, Stirling, Scotland 1981.
  • Dickenson N.A., Fitzpatrick R.W. and Jackson H.  Antifertility Mode of Action of alpha Chlorohydrin: Interaction with Glyceraldehyde-3-Phosphate Dehydrogenase. Presentation to the British Pharmacological Society.  British Journal of Pharmacology, 1979; 61: 456.